These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15876783)

  • 1. Pamidronate--a promising new candidate for the management of spondyloarthropathy.
    Akerkar SM; Bichile LS
    Indian J Med Sci; 2005 Apr; 59(4):165-70. PubMed ID: 15876783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ankylosing spondylitis with pamidronate: an open label study.
    Grover R; Shankar S; Aneja R; Marwaha V; Gupta R; Kumar A
    Ann Rheum Dis; 2006 May; 65(5):688-9. PubMed ID: 16611869
    [No Abstract]   [Full Text] [Related]  

  • 4. New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
    Davis JC; Huang F; Maksymowych W
    Rheum Dis Clin North Am; 2003 Aug; 29(3):481-94, viii. PubMed ID: 12951863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.
    Slobodin G; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M
    Clin Rheumatol; 2010 Jul; 29(7):793-4. PubMed ID: 20111975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of pamidronate in the treatment of refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Leclercq S; Skeith K; Yan A; Russell AS
    J Rheumatol; 1998 Apr; 25(4):714-7. PubMed ID: 9558174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of active ankylosing spondylitis with pamidronate.
    Haibel H; Brandt J; Rudwaleit M; Soerensen H; Sieper J; Braun J
    Rheumatology (Oxford); 2003 Aug; 42(8):1018-20. PubMed ID: 12869678
    [No Abstract]   [Full Text] [Related]  

  • 9. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.
    Cairns AP; Wright SA; Taggart AJ; Coward SM; Wright GD
    Ann Rheum Dis; 2005 Feb; 64(2):338-9. PubMed ID: 15096328
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al.
    Singh R; Menon Y; Cuchacovich R; Espinoza LR
    Arthritis Rheum; 2003 Feb; 48(2):583-4; author reply 584. PubMed ID: 12571878
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases.
    Toussirot E; Le Huédé G; Lohse A; Cédoz JP; Wendling D
    Clin Exp Rheumatol; 2006; 24(3):348. PubMed ID: 16870109
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
    Maksymowych WP; Lambert R; Jhangri GS; Leclercq S; Chiu P; Wong B; Aaron S; Russell AS
    J Rheumatol; 2001 Jan; 28(1):144-55. PubMed ID: 11196517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kaleidoscopic presentation of the spondyloarthritis concept in a female patient.
    De Langhe E; Lories R; Maenaut K; De Vlam K
    Joint Bone Spine; 2011 Dec; 78(6):638-40. PubMed ID: 21703901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamidronate in the treatment of Paget's disease.
    Selby PL
    Bone; 1999 May; 24(5 Suppl):57S-58S. PubMed ID: 10321930
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ankylosing spondylitis].
    El Maghraoui A
    Presse Med; 2004 Nov; 33(20):1459-64. PubMed ID: 15611681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in ankylosing spondylitis treatment.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2003 Jan; 4(1):1-12. PubMed ID: 12517239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2005 Jan; 6(1):35-43. PubMed ID: 15709881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center.
    Sarkar RN; Phaujdar S; De D; Bhattacharyya K
    Rheumatol Int; 2012 Dec; 32(12):3945-50. PubMed ID: 22200806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.
    Gandrud LM; Cheung JC; Daniels MW; Bachrach LK
    J Pediatr Endocrinol Metab; 2003; 16(6):887-92. PubMed ID: 12948302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.